Savant Capital’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.9K Buy
19,219
+604
+3% +$2.2K ﹤0.01% 1812
2026
Q1
$73.5K Buy
+18,615
New +$93.8K ﹤0.01% 1478
2025
Q1
Sell
-10,380
Closed -$99.9K 1289
2024
Q4
$99.9K Buy
+10,380
New +$80.9K ﹤0.01% 1378

Other funds holding MDXG

Savant Capital's MDXG Position: Q2 2026 in Review

Savant Capital increased its MiMedx Group (MDXG) stake by 3.2% in Q2 2026, buying an estimated $2.2K and bringing the position to 19,219 shares worth $75.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1812.

Savant Capital first reported a position in MDXG in Q4 2024 and has held it in 3 quarters since. The position peaked at $99.9K in Q4 2024. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Savant Capital held 19,219 shares of MiMedx Group worth $75.9K as of Q2 2026.
  • Savant Capital bought 604 MiMedx Group shares in Q2 2026, an estimated $2.2K.
  • MiMedx Group made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1812 holding.
  • Savant Capital first reported a position in MiMedx Group in Q4 2024 and has held it in 3 quarters since.
  • Savant Capital's MiMedx Group position peaked at $99.9K in Q4 2024.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.